#7715 on the rich list of 14,452 insiders
Neena M. Patil
EVP & Chief Legal Officer at Jazz Pharmaceuticals; Director at Teleflex.
$11.9M
in disclosed stock, −$549K (−4.42%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 7715th of 14,452
- Companies held
- 2
- Largest holding
- JAZZ, 94.9% of total
- Latest SEC filing
- Sep 10, 2026
What the $11.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals JAZZ Ordinary Shares | Directly | 47,671 | $236.45 | $11.3M | 94.9% | Form 4, Sep 10, 2026 |
| Teleflex TFX Common Stock | Directly | 3,716 | $163.40 | $607K | 5.1% | Form 4, May 15, 2026 |
Share counts are the amounts Neena M. Patil reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Sold | JAZZ | 1,200 | $240.94 | $289K | View |
| Jun 10, 2026 | Sold | JAZZ | 1,200 | $231.83 | $278K | View |
| May 28, 2026 | Sold | JAZZ | 1,192 | $236.97 | $282K | View |
| Feb 26, 2026 | Sold | JAZZ | 875 | $192.07 | $168K | View |
| Feb 26, 2026 | Sold | JAZZ | 15,555 | $190.28 | $3.0M | View |
| Feb 26, 2026 | Sold | JAZZ | 2,916 | $189.81 | $553K | View |
| Feb 26, 2026 | Sold | JAZZ | 11,529 | $191.65 | $2.2M | View |
| Feb 26, 2026 | Sold | JAZZ | 3,523 | $193.58 | $682K | View |
| Feb 26, 2026 | Sold | JAZZ | 1,061 | $190.00 | $202K | View |
| Feb 26, 2026 | Sold | JAZZ | 549 | $190.80 | $105K | View |
| Feb 26, 2026 | Sold | JAZZ | 1,784 | $191.88 | $342K | View |
| Feb 26, 2026 | Sold | JAZZ | 1,009 | $192.79 | $195K | View |
| Feb 26, 2026 | Sold | JAZZ | 197 | $193.60 | $38K | View |
| Feb 26, 2026 | Sold | JAZZ | 16,602 | $192.53 | $3.2M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7712 | Daniel P. Govin Chief Operating Officer (COO), Sterling Infrastructure. The Woodlands, TX | $11.9M |
| 7713 | Toni Townes-Whitley Chief Executive Officer, Science Applications International. New York, NY | $11.9M |
| 7714 | David Boulette Chief Executive Officer, Eva Live. Las Vegas, NV | $11.9M |
| 7715 | Neena M. Patil EVP & Chief Legal Officer, Jazz Pharmaceuticals | $11.9M |
| 7716 | Michael S. Brown Director, Regeneron Pharmaceuticals. Tarrytown, NY | $11.9M |
| 7717 | Braden M Leonard 10% owner, Enliven Therapeutics. Zionsville, IN | $11.9M |
| 7718 | Mayur Kapani Chief Technology Officer, Intercontinental Exchange. Atlanta, GA | $11.9M |
Other Jazz Pharmaceuticals insiders
All JAZZ insiders- Seamus Mulligan$304MDirector. #674 overall
- Bruce C. Cozadd$84.5MDirector. #1697 overall
- Renee D. Gala$33.2MPresident & CEO. #3403 overall
- Robert Iannone$15.5MEVP, Global Head of R&D & CMO. #6257 overall
- Philip L. Johnson$13.3MEVP & Chief Financial Officer. #7069 overall
- Daniel N. Swisher, Jr$13.0MPresident and COO. #7049 overall
Questions
How much stock does Neena M. Patil own?
Neena M. Patil holds $11,879,002 in listed stock based on SEC filings and current prices, mostly Jazz Pharmaceuticals (JAZZ). That ranks 7715th on the Stock Rich List.
Is this Neena M. Patil's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Neena M. Patil last buy or sell stock?
The most recent open-market trade on file is a sale of 1,200 JAZZ shares on Sep 10, 2026 at $240.94.